Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Current Debt (2012 - 2013)

Updated

Ani Pharmaceuticals (ANIP) reported Current Debt of -$4.07 million for FY2013, compared with $1 million in FY2012.

Analysis

Ani Pharmaceuticals (ANIP) Current Debt (2012 - 2013) Analysis & Trends

  • According to Business Quant data, Current Debt came in at $1 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -4.44 Mn
Mar 31, 2013 372,000.00
Dec 31, 2012 636,638.00
Sep 30, 2012 170,796.00
API Access

Ani Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ANIP&period=max&api_key=YOUR_API_KEY